Skip to main navigation Skip to search Skip to main content

Programmed Death-1 or Programmed Death Ligand-1 Blockade in Patients with Platinum-resistant Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis(Figure presented.)

Research output: Contribution to journalReview articlepeer-review

44 Scopus citations

Abstract

Restricted mean survival time estimates may be used to benchmark survival outcomes and inform future trial design.Programmed death-1 and programmed death ligand-1 blockade in patients with platinum-resistant metastatic urothelial cancer yield comparable survival outcomes.

Original languageEnglish
Pages (from-to)782-789
Number of pages8
JournalEuropean Urology
Volume76
Issue number6
DOIs
StatePublished - Dec 2019

Keywords

  • Bladder cancer
  • Immune checkpoint blockade
  • Meta-analysis
  • Programmed death ligand-1 blockade
  • Programmed death-1 blockade
  • Urothelial cancer

Fingerprint

Dive into the research topics of 'Programmed Death-1 or Programmed Death Ligand-1 Blockade in Patients with Platinum-resistant Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis(Figure presented.)'. Together they form a unique fingerprint.

Cite this